|
2024
|
Invention
|
Amide prodrugs and uses thereof. Described herein are amide prodrugs, methods of making such comp... |
|
2023
|
Invention
|
Methods for the treatment of depression. Provided herein are methods for treating depression with... |
|
|
Invention
|
Methods for the treatment of depression |
|
|
Invention
|
Amide prodrugs and uses thereof. 55), methods of making such compounds, pharmaceutical compositio... |
|
2022
|
Invention
|
Fatty acid amide hydrolase (faah) cleavable prodrugs of brain targeting actives and combination w... |
|
|
Invention
|
Fatty acid amide hydrolase (faah) cleavable prodrugs of thyromimetics and combination with periph... |
|
2021
|
Invention
|
Thyromimetics.
Compounds are provided herein function as thyromimetics and have utility for trea... |
|
|
Invention
|
Thyromimetics.
Disclosed herein are thyromimetic compounds having utility for treating diseases ... |
|
|
Invention
|
Thyromimetics.
Compounds provided herein function as thyromimetics and have utility for treating... |
|
|
Invention
|
Thyromimetics. Disclosed herein are thyromimetic compounds having utility for treating diseases s... |
|
|
Invention
|
Thyromimetics. Compounds provided herein function as thyromimetics and have utility for treating ... |
|
|
Invention
|
Thyromimetics. Compounds are provided herein function as thyromimetics and have utility for treat... |
|
|
Invention
|
Isotopic thyromimetic compounds.
Isotopic compounds are provided that function as thyromimetics,... |
|
|
Invention
|
Isotopic thyromimetic compounds. Isotopic compounds are provided that function as thyromimetics, ... |
|
2020
|
Invention
|
Novel thyromimetics.
Compounds are provided having the structure of Formula (I) or a pharmaceuti... |
|
|
Invention
|
Novel thyromimetics. Compounds are provided having the structure of Formula (I) or a pharmaceutic... |
|
|
P/S
|
Pharmaceutical preparations for treating central nervous
system (CNS) disorders; therapeutic age... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of central nervous system (CNS) diseases and disord... |
|
|
P/S
|
Pharmaceutical preparations for treating central nervous system (CNS) disorders; therapeutic agen... |
|
|
P/S
|
Pharmaceutical preparations; therapeutic agents;
thyromimetic pharmaceutical preparations for th... |
|
|
Invention
|
Thyromimetics. Compounds are provided having the structure of Formula (I):
2 and n are as define... |
|
|
Invention
|
Novel thyromimetics. Compounds are provided having the structure of Formula (I): or a pharmaceuti... |
|
2019
|
Invention
|
Thyromimetics. Compounds are provided having the structure of Formula (I):
1 are as defined here... |
|
|
Invention
|
Novel thyromimetics. Compounds are provided having the following structure of Formula (I) or a ph... |
|
|
P/S
|
pharmaceutical preparations, namely, pharmaceutical preparations for treating central nervous sys... |
|
2018
|
Invention
|
Novel thyromimetics. Compounds are provided having the structure of Formula (I) : (I) or a pharma... |
|
2009
|
Invention
|
Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound. A novel pyridyl non... |
|
2006
|
Invention
|
Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound. To provide a compou... |
